Interestingly, when using an assay targeting all CDKN2a transcripts, i.e. both p16INK4a and p14ARF mRNA, the expression levels increased in a stepwise fashion when comparing control mucosa, non-cancerous mucosa and tumor tissue. This evidence concerns the gene CDKN2A and neoplasm.